Image

Chromatic Multifocal Pupillometer for Detection and Follow-up of Acute Head Injury

Chromatic Multifocal Pupillometer for Detection and Follow-up of Acute Head Injury

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

Traumatic Brain Injury (TBI) is a common injury in combat, terrorist attacks and sports such as football and hockey. Unnecessary delays in the diagnosis and treatment of brain damage in patients who can benefit from evacuation procedures can lead to worse brain injury, worse outcome and, sometimes, unnecessary death. However, there is no reliable and sensitive method for diagnosis of TBI severity in the field. In this study we will examine the feasibility of using this a multifocal chromatic pupillometer for monitoring TBI, by examining the pupillary response to multifocal chromatic stimuli in intracranial pressure (ICP)-monitored severe TBI patients. As control, normal subjects will be tested for pupillary responses using this device.

Description

To examine the feasibility of using the multifocal chromatic pupillometer for monitoring TBI, the pupillary response to multifocal chromatic stimuli will be assessed in 20 healthy subjects and 20 ICP-monitored severe TBI patients.

The portable pupillometer will be tested in 20 healthy volunteers. Their pupillary responses will be measured 3 times/day for 1 week.

Pupillary response of 20 severe TBI patients will be evaluated as detailed below at the following time points:

  1. At admittance to ICU, prior to insertion of ICP and CT scan
  2. Prior to CT scans that are routinely performed at day 3 and 7 post injury
  3. Routinely at the beginning of every medical personnel shift for 7 days (3 times a day).
  4. With every change in ICP(more than 5 mmHg for more then 15 min) Data will be recorded and analyzed.

Eligibility

Inclusion Criteria:

  • Healthy subjects -
  • Male or female patients, age between 18 and 70 years, inclusive
  • Informed written consent will be obtained from all participants.
  • Normal eye examination
  • Best-corrected visual acuity (BCVA) of 20/20
  • Normal color vision test (Roth-28-hue test)
  • Written informed consent to participate in the study,
  • TBI-patients:
  • Male or female patients, age between 18 and 70 years, inclusive
  • Initiation of study before the insertion of the ICP monitor.
  • TBI diagnosed by history and clinical examination
  • Glasgow Coma Scale (GCS) score between 3 and 8, inclusive
  • Evidence of TBI confirmed by abnormalities consistent with trauma on CT scan upon admission (diffuse injury II-IV, evacuated and non-evacuated mass lesion, Marshall's CT Classification)
  • Indication for ICP monitoring
  • Written informed consent to participate in the study, signed by a family member and independent physician.

Exclusion Criteria:

  • Healthy subjects
  • History of past or present ocular disease
  • Use of any topical or systemic medications that could adversely influence efferent pupil movements
  • TBI-patients
  • High levels of barbiturate medications as they abolish pupillary responsiveness
  • Coma suspected to be primarily due to other causes (e.g. alcohol)
  • Preexisting clinically significant disease or chronic condition that can be ascertained at the time of admission and could affect pupillary response or measurement (such as known retinal dystrophy disease, glaucoma or dense cataract.

Study details
    Traumatic Brain Injury (TBI) Patients

NCT02030366

Sheba Medical Center

29 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.